ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,548,081 | -11.1% | 75,553 | -13.7% | 0.00% | 0.0% |
Q2 2023 | $1,740,533 | +43.7% | 87,596 | +23.8% | 0.00% | +100.0% |
Q1 2023 | $1,211,622 | -5.4% | 70,731 | +8.0% | 0.00% | 0.0% |
Q4 2022 | $1,281,346 | +157.8% | 65,475 | +110.2% | 0.00% | 0.0% |
Q3 2022 | $497,000 | +15.9% | 31,154 | -0.2% | 0.00% | – |
Q2 2022 | $429,000 | -10.8% | 31,221 | +2.9% | 0.00% | – |
Q1 2022 | $481,000 | -22.2% | 30,345 | +7.2% | 0.00% | – |
Q4 2021 | $618,000 | -22.5% | 28,302 | +6.2% | 0.00% | – |
Q3 2021 | $797,000 | -26.7% | 26,659 | +8.6% | 0.00% | -100.0% |
Q2 2021 | $1,087,000 | -0.1% | 24,553 | +0.1% | 0.00% | 0.0% |
Q1 2021 | $1,088,000 | -19.6% | 24,523 | -0.6% | 0.00% | 0.0% |
Q4 2020 | $1,354,000 | -13.8% | 24,668 | -64.1% | 0.00% | 0.0% |
Q3 2020 | $1,570,000 | +94.5% | 68,646 | +78.0% | 0.00% | 0.0% |
Q2 2020 | $807,000 | -28.1% | 38,557 | -21.8% | 0.00% | 0.0% |
Q4 2019 | $1,122,000 | +35.0% | 49,289 | -31.0% | 0.00% | 0.0% |
Q3 2019 | $831,000 | +7.1% | 71,395 | +37.9% | 0.00% | 0.0% |
Q2 2019 | $776,000 | +163.9% | 51,758 | +209.4% | 0.00% | – |
Q1 2019 | $294,000 | -28.5% | 16,731 | -39.7% | 0.00% | – |
Q4 2018 | $411,000 | +68.4% | 27,765 | +180.9% | 0.00% | – |
Q3 2018 | $244,000 | -28.9% | 9,885 | -43.5% | 0.00% | – |
Q2 2018 | $343,000 | – | 17,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |